.png){kind=small}
.png){kind=small}
BackTable / Urology / Podcast / Episode #143
Navigating Upper Tract Urothelial Carcinoma
with Dr. Padraic O'Malley
In this episode, host Dr. Jose Silva and Dr. Padraic O’Malley, a urologic oncologist from University of Florida Health, discuss how to diagnose and treat upper tract urothelial carcinoma.
Be part of the conversation. Put your sponsored messaging on this episode. Learn how.
BackTable, LLC (Producer). (2023, December 20). Ep. 143 – Navigating Upper Tract Urothelial Carcinoma [Audio podcast]. Retrieved from https://www.backtable.com
Stay Up To Date
Follow:
Subscribe:
Sign Up:
Podcast Contributors
Synopsis
Referencing official guidelines and personal experiences, the doctors discuss various treatments such as tumor ablation, JELMYTO, neoadjuvant chemotherapy, and nephroureterectomy. They also discuss the role of lymph node dissection and the significance of Lynch syndrome. Additionally, they touch upon the Thulium laser and updated staging guidelines. The episode concludes with discussions about follow-up care, and the doctors agree on the need for a standardized reporting system and risk stratification guidelines for improved patient management.
Timestamps
00:00 - Introduction
02:09 - Initial Presentation of Patients with Upper Tract Urothelial Carcinoma
10:54 - Discussion on Lynch Syndrome
14:27 - Risk Stratification in Patients
15:37 - Tumor Ablation and Intracavitary Therapies
26:47 - The Use of Thulium Laser in Treatment
28:50 - Discussion on High Volume Disease
32:39 - Discussion on High Grade Tumors
38:23 - The Role of Neoadjuvant Chemotherapy
43:02 - Post-Treatment Follow Up
45:18 - Standardized Reporting in Guidelines
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.
Up Next
Articles
Topics
